CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+0.8%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.72B
AUM Growth
+$1.72B
(+6.9%)
Cap. Flow
+$90.8M
Cap. Flow
% of AUM
5.28%
Top 10 Holdings %
Top 10 Hldgs %
46.76%
Holding
56
New
9
Increased
7
Reduced
12
Closed
10
Top Buys
| 1 |
ENDP
Endo International plc
ENDP
|
$78.7M |
| 2 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$75.3M |
| 3 |
Cigna
CI
|
$64M |
| 4 |
Gilead Sciences
GILD
|
$62.6M |
| 5 |
Perrigo
PRGO
|
$51.7M |
Top Sells
| 1 |
STJ
St Jude Medical
STJ
|
$68.8M |
| 2 |
AbbVie
ABBV
|
$51.4M |
| 3 |
NUVA
NuVasive, Inc.
NUVA
|
$44.8M |
| 4 |
Quest Diagnostics
DGX
|
$42.9M |
| 5 |
Masimo
MASI
|
$41.8M |
Sector Composition
| 1 | Healthcare | 77.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $144M | 6.97% | 2,870,000 +620,000 | +28% | +$31.1M |
|
2
Viatris
VTRS
$12.3B
| $118M | 5.73% | 2,740,000 +890,000 | +48% | +$38.5M |
|
|
ENDP
3
DELISTED
Endo International plc
ENDP
| $78.7M | 3.8% | +5,045,000 | New | +$78.7M |
|
|
CSII
4
DELISTED
Cardiovascular Systems, Inc.
CSII
| $75.3M | 3.64% | +4,100,000 | New | +$75.3M |
|
|
MDCO
5
DELISTED
Medicines Co
MDCO
| $67.3M | 3.25% | 2,000,000 -500,000 | -20% | -$16.8M |
|
6
Biogen
BIIB
$19.4B
| $66.5M | 3.21% | 275,000 +100,000 | +57% | +$24.2M |
|
|
7
Cigna
CI
$80.3B
| $64M | 3.09% | +500,000 | New | +$64M |
|
|
GHDX
8
DELISTED
Genomic Health, Inc.
GHDX
| $63.7M | 3.08% | 2,458,100 | – | – |
|
9
Orthofix Medical
OFIX
$592M
| $63.6M | 3.07% | 1,500,000 | – | – |
|
|
10
Gilead Sciences
GILD
$140B
| $62.6M | 3.02% | +750,000 | New | +$62.6M |
|
11
Brookdale Senior Living
BKD
$1.83B
| $61.8M | 2.98% | 4,000,000 -1,000,000 | -20% | -$15.4M |
|
12
Select Medical
SEM
$1.61B
| $60.6M | 2.93% | 5,575,000 | – | – |
|
13
Nektar Therapeutics
NKTR
$568M
| $60.5M | 2.92% | 4,250,000 -250,000 | -6% | -$3.56M |
|
14
LivaNova
LIVN
$3.08B
| $60.3M | 2.91% | 1,200,000 | – | – |
|
|
15
Perrigo
PRGO
$3.27B
| $51.7M | 2.5% | +570,000 | New | +$51.7M |
|
|
LDRH
16
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| $50.8M | 2.46% | 1,375,000 -875,000 | -39% | -$32.3M |
|
17
Cencora
COR
$56.5B
| $49.6M | 2.4% | +625,000 | New | +$49.6M |
|
|
NUVA
18
DELISTED
NuVasive, Inc.
NUVA
| $44.8M | 2.16% | 750,000 -750,000 | -50% | -$44.8M |
|
|
UAM
19
DELISTED
Universal American Corp
UAM
| $44.5M | 2.15% | 5,875,000 | – | – |
|
|
WMGI
20
DELISTED
Wright Medical Group Inc
WMGI
| $43M | 2.08% | 2,475,000 +1,022,400 | +70% | +$17.8M |
|
21
Community Health Systems
CYH
$387M
| $41.6M | 2.01% | +3,450,000 | New | +$41.6M |
|
22
Alkermes
ALKS
$4.78B
| $40.5M | 1.96% | 937,300 -262,700 | -22% | -$11.4M |
|
|
ELGX
23
DELISTED
Endologix Inc
ELGX
| $37.4M | 1.81% | 3,000,000 -864,500 | -22% | -$10.8M |
|
24
Bausch Health
BHC
$2.74B
| $33.4M | 1.61% | 1,656,000 -344,000 | -17% | -$6.93M |
|
25
Tenet Healthcare
THC
$16.3B
| $31.1M | 1.5% | 1,125,000 -375,000 | -25% | -$10.4M |
|